These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23234246)

  • 1. Synthesis and SAR of novel Re/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia.
    Lu G; Hillier SM; Maresca KP; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    J Med Chem; 2013 Jan; 56(2):510-20. PubMed ID: 23234246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII.
    Khloya P; Celik G; SitaRam ; Vullo D; Supuran CT; Sharma PK
    Eur J Med Chem; 2014 Apr; 76():284-90. PubMed ID: 24589484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of
    Nakai M; Pan J; Lin KS; Thompson JR; Nocentini A; Supuran CT; Nakabayashi Y; Storr T
    J Inorg Biochem; 2018 Aug; 185():63-70. PubMed ID: 29778927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [(Cp-R)M(CO)3] (M=Re or 99mTc) Arylsulfonamide, arylsulfamide, and arylsulfamate conjugates for selective targeting of human carbonic anhydrase IX.
    Can D; Spingler B; Schmutz P; Mendes F; Raposinho P; Fernandes C; Carta F; Innocenti A; Santos I; Supuran CT; Alberto R
    Angew Chem Int Ed Engl; 2012 Apr; 51(14):3354-7. PubMed ID: 22344779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors: transepithelial transport of thioureido sulfonamide inhibitors of the cancer-associated isozyme IX is dependent on efflux transporters.
    Vullo D; Steffansen B; Brodin B; Supuran CT; Scozzafava A; Nielsen CU
    Bioorg Med Chem; 2006 Apr; 14(7):2418-27. PubMed ID: 16321542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia.
    Akurathi V; Dubois L; Lieuwes NG; Chitneni SK; Cleynhens BJ; Vullo D; Supuran CT; Verbruggen AM; Lambin P; Bormans GM
    Nucl Med Biol; 2010 Jul; 37(5):557-64. PubMed ID: 20610160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
    Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides.
    Ozensoy O; Puccetti L; Fasolis G; Arslan O; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4862-6. PubMed ID: 16168653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and biological evaluation of ⁹⁹mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers.
    Akurathi V; Dubois L; Celen S; Lieuwes NG; Chitneni SK; Cleynhens BJ; Innocenti A; Supuran CT; Verbruggen AM; Lambin P; Bormans GM
    Eur J Med Chem; 2014 Jan; 71():374-84. PubMed ID: 24378650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
    Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
    J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors: design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes.
    Cecchi A; Ciani L; Winum JY; Montero JL; Scozzafava A; Ristori S; Supuran CT
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3475-80. PubMed ID: 18513964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of small molecule carbonic anhydrase IX inhibitors.
    Supuran CT
    BJU Int; 2008 Jun; 101 Suppl 4():39-40. PubMed ID: 18430122
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes.
    Moeker J; Peat TS; Bornaghi LF; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2014 Apr; 57(8):3522-31. PubMed ID: 24689792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship.
    Gao R; Liao S; Zhang C; Zhu W; Wang L; Huang J; Zhao Z; Li H; Qian X; Xu Y
    Eur J Med Chem; 2013 Apr; 62():597-604. PubMed ID: 23429054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors.
    Winum JY; Cecchi A; Montero JL; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3302-6. PubMed ID: 15908201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
    Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A
    Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors.
    Thiry A; Ledecq M; Cecchi A; Frederick R; Dogné JM; Supuran CT; Wouters J; Masereel B
    Bioorg Med Chem; 2009 Jan; 17(2):553-7. PubMed ID: 19097911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT
    Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.